Evidence map›Paper›PMID 19764834›Full record

ArticleDiabetes technology & therapeutics2009

New and improved methods to characterize glycemic variability using continuous glucose monitoring.

David Rodbard

Registry-linked trialAbstract read
PubMed Publisher
In one paragraph

Article in Diabetes technology & therapeutics, 2009. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01524705 (FLAT-SUGAR), which is not on this map. Cited by 105 papers.

0numbers the graph read from it
0cells of the map it votes in
105citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01524705 phase4completedstarted 2012, after this paper: background citation

FLAT-SUGAR: FLuctuATion Reduction With inSULin and Glp-1 Added togetheR

Ran2012Enrolled102Registered outcomes4Posted comparisons3ConditionsType 2 DiabetesArmsexenatide, Insulin glargine, Metformin, Prandial insulin
Open the trial in the graph
3 · Its place in the literature

Who cites it

105 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Trial
  4. Assessment of Glucose Control Metrics by Discriminant Ratio.Diabetes technology & therapeutics · 2020
    Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Clinical impact of sample interference on intensive insulin therapy in severely burned patients: a pilot study.Journal of burn care & research : official publication of the American Burn Association
    Trial
  15. Article
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article

45 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

David RodbardBiomedical Informatics Consultants LLC, Potomac, Maryland 20854-4721, USA. drodbard@comcast.net

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundGlycemic variability is a possible risk factor for development of complications from diabetes. Numerous methods have been used to characterize glycemic variability.

methodsWe propose several new methods to characterize glycemic variability. We evaluated these methods empirically and theoretically and compared them with previous methods.

resultsWe describe (1) extension and generalization of the mean amplitude of glycemic excursion (MAGE), i.e., "within day variability," (2) extension and generalization of the mean of daily differences (MODD), i.e., the "between day-within time points variability," (3) "between daily means variability," (4) "between time points variability" of the glucose profile averaged over several days, (5) "within series variability" for a time segment of any arbitrary length, (6) new measures of the stability of the daily glycemic patterns, (7) new types of graphical displays, including within day variability, between day-within time points variability, and between daily means variability versus total variability, and between daily means variability versus within day variability, and (8) new methods to evaluate whether within series and between day-within time points variability fluctuate systematically by time of day. We examined the new measures in relation to previous measures of glycemic variability using correlation analysis on a clinical dataset for 85 subjects. MAGE, MODD, and continuous overall net glycemic action (CONGA(n)) are directly proportional to total standard deviation (SD). MAGE is highly correlated with both total SD and within day variability but weakly correlated with measures of between day variability. MODD is highly correlated with between day-within time points variability and total SD but weakly correlated with measures of within day variability.

conclusionsWe provide a systematic, logical framework to characterize multiple aspects of glycemic variability and have implemented a simple, practical computing format. This approach can help clinical researchers and clinicians identify the major sources of variability for any given patient and monitor responses to interventions.

Indexed as

Monitoring, AmbulatoryAlgorithmsAnalysis of VarianceBlood GlucoseData Interpretation, StatisticalDiabetes ComplicationsDiabetes MellitusHumansNormal DistributionNumerical Analysis, Computer-AssistedRisk FactorsStatistics as TopicTime FactorsBlood Glucose

Identifiers

PMID19764834

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.